Colin Reisner

4.5k citations

122 papers · 3.0k indexed · 1 hit paper · h-index 22

Impact in

Physiology top 0.5%
- Asthma and respiratory diseases
Pulmonary and Respiratory Medicine top 0.5%
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Respiratory Support and Mechanisms
- Inhalation and Respiratory Drug Delivery
- Respiratory and Cough-Related Research
- Neonatal Respiratory Health Research

Papers in

Pulmonary and Respiratory Medicine 106
- Inhalation and Respiratory Drug Delivery 82
- Chronic Obstructive Pulmonary Disease (COPD) Research 73
- Respiratory and Cough-Related Research 27
- Respiratory Support and Mechanisms 11
Physiology 66
- Asthma and respiratory diseases 63

Co-authors: Gary T. Ferguson Patrick Darken Yamo Deniz Paul Dorinsky Klaus F. Rabe Earl St. Rose Stephen P. Peters Thomas B. Casale
Journals: Journal of Allergy and Clinical Immunology (11 papers)International Journal of COPD (11 papers)CHEST Journal (11 papers)Respiratory Medicine (7 papers)Annals of Allergy Asthma & Immunology (5 papers)
Partner nations: United States United Kingdom Germany

In The Last Decade

Colin Reisner

115 papers receiving 2.9k citations

Hit Papers

align trajectories log scale

Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD 2020 · 374 citations

Peers

Countries citing papers authored by Colin Reisner

Since Specialization

Citations

This map shows the geographic impact of Colin Reisner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Colin Reisner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Colin Reisner more than expected).

Fields of papers citing papers by Colin Reisner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Colin Reisner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Colin Reisner. The network helps show where Colin Reisner may publish in the future.

Co-authors

The 25 scholars most cited alongside Colin Reisner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Colin Reisner Line = papers co-authored together Colin Reisner links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	255 Amphotericin B Cystetic for Inhalation (CM001): A randomized, double-blind, placebo-controlled, single ascending dose study in healthy volunteers Journal of Cystic Fibrosis ·Анжела Ципан, Michael J. Welsh, T. Kotseva, Michiel van Harten, Colin Reisner	2023	0
2	Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Improves Exacerbation Outcomes in Patients with COPD without a Recent Exacerbation History: A Subgroup Analysis of KRONOS International Journal of COPD ·Fernando J. Martínez, Gary T. Ferguson, Eric Bourne, Shaila Ballal, Patrick Darken, Magnus Aurivillius, Paul Dorinsky, Colin Reisner	2021	11
3	Reduced All-Cause Mortality in the ETHOS Trial of Budesonide/Glycopyrrolate/Formoterol for Chronic Obstructive Pulmonary Disease. A Randomized, Double-Blind, Multicenter, Parallel-Group Study American Journal of Respiratory and Critical Care Medicine ·Fernando J. Martínez, Klaus F. Rabe, Gary T. Ferguson, Jadwiga A. Wedzicha, Dave Singh, Chen Wang, J. Chen, Earl St. Rose, Roopa Trivedi, Shaila Ballal, Patrick Darken, Magnus Aurivillius, Colin Reisner, Paul Dorinsky	2020	147
4	Long-Term Safety and Efficacy of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Japanese Patients with COPD SHILAP Revista de lepidopterología ·Joceneide Cunha dos Santos, Liu Chu, Chetan S. Lohande, J.M. Blackmore, Ouiam Kaddouri, 崔张龙, Ferran Barbé, Anoud Soub, 達雄荒木, Eric Bourne, Shaila Ballal, Kiernan DeAngelis, M. Viñas Véliz, Colin Reisner, Paul Dorinsky	2019	1
5	<p>Efficacy and Safety of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Japanese Patients with COPD: A Subgroup Analysis of the KRONOS Study</p> International Journal of COPD ·Masakazu Ichinose, Yasushi Fukushima, Yoshikazu Inoue, Osamu Hataji, Gary T. Ferguson, Klaus F. Rabe, Nobuya Hayashi, Hiroshi Okada, Y.P. Singh, Eric Bourne, Shaila Ballal, Kiernan DeAngelis, Magnus Aurivillius, Paul Dorinsky, Colin Reisner	2019	12
6	<p>Long-Term Safety and Efficacy of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Japanese Patients with COPD</p> International Journal of COPD ·Masakazu Ichinose, Yasushi Fukushima, Yoshikazu Inoue, Osamu Hataji, Gary T. Ferguson, Klaus F. Rabe, Nobuya Hayashi, Hiroshi Okada, Y.P. Singh, Eric Bourne, Shaila Ballal, Kiernan DeAngelis, Magnus Aurivillius, Colin Reisner, Paul Dorinsky	2019	14
7	A phase III study of triple therapy with budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler 320/18/9.6 μg and 160/18/9.6 μg using co-suspension delivery technology in moderate-to-very severe COPD: The ETHOS study protocol Respiratory Medicine ·Klaus F. Rabe, Fernando J. Martínez, Gary T. Ferguson, Chen Wang, Dave Singh, Jadwiga A. Wedzicha, Roopa Trivedi, Earl St. Rose, Shaila Ballal, Julie McLaren, Patrick Darken, Colin Reisner, Paul Dorinsky	2019	24
8	The pharmacokinetics of three doses of budesonide/glycopyrronium/formoterol fumarate dihydrate metered dose inhaler compared with active controls: A Phase I randomized, single-dose, crossover study in healthy adults Pulmonary Pharmacology & Therapeutics ·Patrick Darken, Paolo B. DePetrillo, Colin Reisner, Earl St. Rose, Paul Dorinsky	2018	13
9	A randomized study using functional respiratory imaging to characterize bronchodilator effects of glycopyrrolate/formoterol fumarate delivered by a metered dose inhaler using co-suspension delivery technology in patients with COPD International Journal of COPD ·Wilfried De Backer, Jan De Backer, Wim Vos, Cherukuri Sowmya, Cedric Van Holsbeke, 富田任, Bita Hajian, Shahid Siddiqui, Martin Jenkins, Colin Reisner, Ubaldo J. Martin	2018	21
10	Randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of three doses of co-suspension delivery technology glycopyrronium MDI in Japanese patients with moderate-to-severe COPD International Journal of COPD ·Yasushi Fukushima, Yuji Nakatani, Yumiko Ide, Hisakuni Sekino, Earl St. Rose, Shahid Siddiqui, Andrea Maes, Colin Reisner	2018	6
11	Efficacy, safety, and pharmacokinetics of budesonide/formoterol fumarate delivered via metered dose inhaler using innovative co-suspension delivery technology in patients with moderate-to-severe COPD International Journal of COPD ·Edward Kerwin, Thomas M. Siler, Samir Arora, Patrick Darken, Earl St. Rose, Colin Reisner	2018	2
12	An Open-Label Study Evaluating the Performance of the Dose Indicator in a Metered Dose Inhaler Delivering Glycopyrrolate and Formoterol Fumarate in Patients with Moderate-to-Very Severe Chronic Obstructive Pulmonary Disease Journal of Aerosol Medicine and Pulmonary Drug Delivery ·出浦正倫, Gregory Feldman, Faisal Fakih, Peter Mack, Andrea Maes, Shahid Siddiqui, Earl St. Rose, Colin Reisner	2018	3
13	Determinants of Response to Roflumilast in Severe Chronic Obstructive Pulmonary Disease: Pooled Analysis of Two Randomized Trials American Journal of Respiratory and Critical Care Medicine ·Fernando J. Martínez, Klaus F. Rabe, Peter M.A. Calverley, Leonardo M. Fabbri, Sanjay Sethi, Emílio Pizzichini, Andrew McIvor, Antonio Anzueto, Vijay Alagappan, Shahid Siddiqui, Colin Reisner, Sofia Zetterstrand, Stephen F Gregorius, 秦邦佑, Tashpulatov X Sh, Stephen I. Rennard	2018	54
14	Effect of Roflumilast and Inhaled Corticosteroid/Long-Acting β2-Agonist on Chronic Obstructive Pulmonary Disease Exacerbations (RE2SPOND): A Randomized Clinical Trial American Journal of Respiratory and Critical Care Medicine ·Fernando J. Martínez, Klaus F. Rabe, Sanjay Sethi, Emílio Pizzichini, Andrew McIvor, Antonio Anzueto, Vijay K. T. Alagappan, Shahid Siddiqui, Ludmyla Rekeda, Christopher J. Miller, Sofia Zetterstrand, Colin Reisner, Stephen I. Rennard	2016	93
15	A randomized study of formoterol fumarate in a porous particle metered-dose inhaler in patients with moderate-to-severe COPD Respiratory Medicine ·Dean Quinn, J. Paul Seale, Colin Reisner, Tracy Fischer, Michael A. Golden, Carlos Fernández‐Peña, Patrick Darken, Earl St. Rose, Mervyn Thomas, A. A. Aslanyan, Yun-Fan Xie	2014	10
16	Pearl's PT010 triple combination provides comparable budesonide exposure to symbicort and comparable glycopyrronium and formoterol exposure to PT003 European Respiratory Journal ·Colin Reisner, Carlos Fernández‐Peña, Patrick Darken, Paolo B. DePetrillo, Earl St. Rose, Tracy Fischer, M. Rivero-Ayala, Michael M. C. Kong, Liu Lian-ke, Shahid Siddiqui, 健悟廣戸, Yun-Fan Xie	2014	3
17	Pooled analyses of QTcF across six phase 2b studies with glycopyrrolate-formoterol fumarate (GFF) MDI (PT003), its components and active comparators European Respiratory Journal ·Leonardo M. Fabbri, Roberto Rodríguez-Roisin, Yun-Fan Xie, A El-Daker, Patrick Darken, Earl St. Rose, Shatha Abd, Colin Reisner	2013	2
18	Clinically Relevant Improvements in Asthma-Related Quality of Life in Patients Receiving Omalizumab as Add-On Therapy Journal of Allergy and Clinical Immunology ·William W. Busse, Helen Fox, K. Surrey, Robert Maykut, Colin Reisner	2006	1
19	OMALIZUMAB IMPROVES SYMPTOMS AND REDUCES RESCUE BETA-AGONIST USE IN OLDER PATIENTS WITH UNCONTROLLED ASTHMA CHEST Journal ·Robert Maykut, Marc Massanari, Farid Kianifard, Yamo Deniz, Colin Reisner, Robert K. Zeldin, Gregory P. Geba	2005	1
20	Analysis of Inhaled Corticosteroid and Oral Theophylline Use Among Patients With Stable COPD from 1987 to 1995 CHEST Journal ·Wren Kominos‐Marvell, Colin Reisner, Shailendra Menjoge, ANA CAROLLYNE PONTES RIBEIRO COSTA	1999	47

About Colin Reisner

Colin Reisner is a scholar working on Pulmonary and Respiratory Medicine, Physiology, Immunology and Allergy, Endocrine and Autonomic Systems and Complementary and alternative medicine, having authored 122 papers that have together received 3.0k indexed citations. Recurring topics across this work include Inhalation and Respiratory Drug Delivery (82 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (73 papers), Asthma and respiratory diseases (63 papers), Respiratory and Cough-Related Research (27 papers), Respiratory Support and Mechanisms (11 papers), Allergic Rhinitis and Sensitization (5 papers), Advanced Chemical Sensor Technologies (4 papers) and Pharmaceutical studies and practices (4 papers). The work is most often cited by research in Physiology (2.2k citations), Pulmonary and Respiratory Medicine (2.4k citations), Immunology and Allergy (305 citations), Issues, ethics and legal aspects (26 citations) and Emergency Medical Services (97 citations). Colin Reisner has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Gary T. Ferguson, Patrick Darken, Yamo Deniz, Paul Dorinsky, Klaus F. Rabe, Earl St. Rose, Stephen P. Peters, Thomas B. Casale, Shaila Ballal and Stephen T. Holgate. Their work appears in journals such as Journal of Allergy and Clinical Immunology, International Journal of COPD, CHEST Journal, Respiratory Medicine and Annals of Allergy Asthma & Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact